Anesthetic impacts on pulmonary function: Implications for cystic fibrosis
- PMID: 35527234
- DOI: 10.1111/pan.14462
Anesthetic impacts on pulmonary function: Implications for cystic fibrosis
Comment on
-
Cystic fibrosis in children: A pediatric anesthesiologist's perspective.Paediatr Anaesth. 2022 Feb;32(2):167-173. doi: 10.1111/pan.14384. Epub 2022 Jan 10. Paediatr Anaesth. 2022. PMID: 34963200 Review.
References
REFERENCES
-
- Williamson D, Sharma A. Cystic fibrosis in children: a pediatric anesthesiologist's perspective. Pediatric Anesthesia. 2022;32(2):167-173. doi:10.1111/pan.14384
-
- Ledowski T, Paech MJ, Patel B, Schug SA. Bronchial mucus transport velocity in patients receiving Propofol and remifentanil versus sevoflurane and remifentanil anesthesia. Anesth Analg. 2006;102:1427-1430.
-
- Zeng C, Lagier D, Lee J-W, Vidal Melo MF. Perioperative pulmonary atelectasis: part I. Biology and Mechanisms. Anesthesiology. 2022;136:181-205.
-
- Tabeling C, Yu H, Wang L, et al. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci. 2015;112(13):E1614-E1623. doi:10.1073/pnas.1421190112
-
- Gaynor J, Ansermino JM. Paediatric total intravenous anaesthesia. BJA Education. 2016;16(11):369-373.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical